Global PAD Medical Device Market Size By Type (Peripheral Vascular Stent, Peripheral Transluminal Angioplasty Balloon Catheters), By Application (Hospitals, Medical Equipment Manufacturing Organizatio...

lobal PAD Medical Device Market Report Description

The Global PAD (Peripheral Artery Disease) Medical Device Market was valued at USD 4.3 billion in 2023 and is projected to reach USD 7.8 billion by 2031, growing at a CAGR of 7.5% during the forecast period from 2023 to 2031. The market's expansion is primarily driven by the rising global prevalence of peripheral artery disease, growing geriatric population, and increasing demand for minimally invasive procedures. Technological advancements in vascular devices and a surge in healthcare expenditure across developing regions further contribute to market growth. PAD medical devices play a critical role in restoring blood flow and preventing complications such as amputations and stroke, making them essential in modern vascular treatment strategies.

Drivers

1. Rising Prevalence of Peripheral Artery Disease (PAD):

The increasing incidence of PAD, especially among the aging population and individuals with diabetes or high cholesterol, is significantly boosting the demand for effective diagnostic and therapeutic medical devices.

2. Technological Advancements in PAD Devices:

Innovations in drug-coated balloons (DCBs), drug-eluting stents (DES), and atherectomy devices are enhancing treatment efficacy and reducing restenosis rates, driving adoption across both developed and emerging markets.

3. Growing Preference for Minimally Invasive Procedures:

Patients and healthcare providers are favoring minimally invasive vascular interventions due to faster recovery times, lower complication risks, and shorter hospital stays, propelling demand for PAD devices.

Restraints

1. High Cost of Advanced PAD Devices:

The high cost of drug-eluting technologies and imaging-guided interventions limits their accessibility, particularly in low-income countries with constrained healthcare budgets.

2. Reimbursement Limitations in Developing Regions:

Insufficient reimbursement policies for PAD treatments in certain regions act as a barrier to widespread adoption, affecting market penetration.

Opportunity

1. Expanding Healthcare Infrastructure in Emerging Markets:

Countries such as India, Brazil, and China are investing heavily in healthcare infrastructure and medical technology, creating lucrative opportunities for PAD device manufacturers.

2. Integration of AI and Imaging Technologies:

The growing integration of artificial intelligence with intravascular imaging and procedural guidance presents a significant opportunity to improve procedural outcomes and tailor personalized treatment plans.

Market by System Type Insights

The stents segment held the largest market share in 2023, attributed to their widespread use in opening narrowed arteries and preventing restenosis. Among these, drug-eluting stents (DES) are preferred for their ability to release medication that inhibits arterial blockages. The atherectomy devices segment is projected to witness the fastest growth, owing to their utility in removing plaque and restoring blood flow in complex lesions.

Market by End-use Insights

Hospitals and ambulatory surgical centers (ASCs) dominated the end-use segment in 2023, collectively accounting for over 70% of market revenue. The increasing shift toward outpatient PAD procedures in ASCs due to cost-efficiency and improved patient outcomes is expected to support sustained growth in this segment. Specialty clinics are also emerging as key providers of PAD treatments, particularly in urban centers.

Market by Regional Insights

North America was the largest regional market in 2023, driven by high disease awareness, favorable reimbursement policies, and early adoption of cutting-edge PAD devices. Europe follows closely, supported by advanced healthcare infrastructure and increasing geriatric population. Asia-Pacific is poised to be the fastest-growing region during the forecast period, underpinned by rising PAD incidence, growing healthcare investments, and improving diagnostic capabilities in countries like China, Japan, and India.

Competitive Scenario

Leading companies in the PAD medical device market include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, BD (Becton, Dickinson and Company), Cardinal Health, Cook Medical, Terumo Corporation, and Philips Healthcare. These players are focusing on product innovation, mergers & acquisitions, and global expansion strategies. Notable developments include:

In 2023, Medtronic launched a new drug-coated balloon designed to treat small vessels in PAD patients, demonstrating improved efficacy in clinical trials.

Boston Scientific acquired a vascular solutions company in 2024 to expand its PAD treatment portfolio and R&D capabilities.

Philips Healthcare introduced AI-powered intravascular imaging tools in 2023, offering enhanced procedural guidance and better patient outcomes.

Scope of Work – Global PAD Medical Device Market

Report Metric Details

Market Size (2023) USD 4.3 billion

Projected Market Size (2031) USD 7.8 billion

CAGR (2023–2031) 7.5%

Market Segments System Type (Stents, Balloons, Atherectomy Devices), End-Use (Hospitals, ASCs, Specialty Clinics), Region

Growth Drivers Rising prevalence of PAD, technological advancements, shift to minimally invasive procedures

Opportunities Emerging markets expansion, AI integration in vascular procedures

Key Market Developments

2023: Medtronic launched a next-gen drug-coated balloon approved for small vessel disease in PAD patients.

2024: Boston Scientific expanded its vascular portfolio through acquisition of a niche PAD treatment company.

2025: Abbott introduced a bioresorbable scaffold for PAD treatment to improve long-term outcomes with minimal restenosis risk.

FAQs

1. What is the current market size of the Global PAD Medical Device Market?

The Global PAD Medical Device Market was valued at USD 4.3 billion in 2023.

2. What is the major growth driver of the Global PAD Medical Device Market?

The market is driven by the rising prevalence of PAD and the growing demand for minimally invasive vascular procedures.

3. Which is the largest region during the forecast period in the Global PAD Medical Device Market?

North America is expected to maintain its dominance due to advanced healthcare infrastructure and early technology adoption.

4. Which segment accounted for the largest market share in the Global PAD Medical Device Market?

The stents segment, particularly drug-eluting stents, accounted for the largest market share in 2023.

5. Who are the key market players in the Global PAD Medical Device Market?

Key players include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, BD, Terumo Corporation, Cook Medical, and Philips Healthcare.

Would you like this formatted as a downloadable Word document as well?